ImClone Systems 2004 Annual Report: Carpe Diem
With FDA approval of Erbitux, a break through treatment for colorectal cancer, secured the ImClone’s future is bright. The company wanted an optimistic, passionate and provocative piece that would communicate these qualities.
The magic: The essence of life happens in the moment and these moments are part of our nature and the essence of life.
The vision: Carpe Diem –seize the day! Capture every sight, every scent,

every moment is precious. ImClone’s innovative treatments extend survival rates; people therefore have more days, more months to “seize the day”.

The experience: The 64 page AR is intended to be reader-friendly and offer a human and humanistic view of the companies activities and aspirations. Based on the “carpe diem” theme, it emphasizes, through intimate photography of “real” people and real nature, the preciousness of every moment of human life and the implicit value of life extending drugs like Erbitux.